drug
MICAFUNGIN SODIUM
Marketedupdated 3mo agoby Xellia Pharmaceuticals USA LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(2)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 15, 2037
~11.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Dec 15, 2037formulationUS 12403173
- Dec 15, 2037formulationUS 12403173
- Dec 15, 2037formulationUS 12403173
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that